Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

Oxford Immunotec Announces Preliminary Revenue for Fourth Quarter and Full Year 2017

The Company plans to release complete financial and operating results for the fourth quarter and full year 2017 prior to market open on Tuesday, February 27, 2018. At this time, the Company also anticipates providing 2018 financial guidance.

Read the rest of entry »

Alta Innovations relaunches as University of Birmingham Enterprise

Alta Innovations Ltd, the technology transfer company for the University of Birmingham, announces it has changed its name to University of Birmingham Enterprise Ltd.  

Read the rest of entry »

J A Kemp Opens Office in Paris

On 1 February 2018, J A Kemp, a leading firm of European and UK Patent and Trade Mark Attorneys, will open an office in Paris. T

Read the rest of entry »

Summit Therapeutics To Present At The Biotech Showcase

Summit Therapeutics plc, the drug discovery and development company advancing therapies for rare diseases and infectious diseases, announces that it will present at the Biotech Showcase(TM), taking place 8-10 January in San Francisco, CA, US. The presentation will take place today, 9 January, at 4:00pm PST.

Read the rest of entry »

European Patent For Arecor’s Proprietary Technology Enabling Highly Concentrated Biotherapeutics

Arecor Ltd, the UK-based leading formulation technology company, focussed on developing superior biopharmaceuticals via the innovative reformulation of proteins and peptides, is pleased to announce the European Patent Office (“EPO”) has issued “Notice of Intention to Grant” for Arecor’s patent application protecting the Company’s proprietary technology used in the development of stable, low-viscosity formulations of highly concentrated protein therapeutics, including monoclonal antibodies such as trastuzumab or ustekinumab or fusion proteins such as abatacept. 

Read the rest of entry »

Examination of Non-sterile Products: Application Note Published in European Pharmaceutical Review

Wickham Laboratories is pleased to announce their most recent Application Note, “Examination of Non-sterile Products: Tests for Specified Microorganisms” which is featured in the December 2017 issue of European Pharmaceutical Review.

Read the rest of entry »

Immunocore Strengthens its Board with Appointments of Laura Wade-Gery and Kristine Peterson as Non-Executive Directors

Immunocore Limited, the world’s leading TCR company focused on delivering first-in-class biologics that transform lives, today announces the appointment of Laura Wade-Gery and Kristine Peterson as Non-Executive Directors.

Read the rest of entry »

Arecor and JDRF Announce Successful Pre-clinical Development of Stable Rapid-Acting, Ultra-Concentrated Insulin for the significantly enhanced treatement of Type 1 Diabetes

“Arecor’s proprietary insulin product to progress into human clinical trials in 2018”

Read the rest of entry »

Oxford Immunotec to Present at the 36th Annual J.P. Morgan Healthcare Conference

Oxford Immunotec Global PLC, a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, will present at the 36th Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2018, at 11:00 a.m. PST (2:00 p.m. EST). The conference will be held at the Westin St. Francis Hotel in San Francisco.

Read the rest of entry »

Wessex Academic Health Science Network and Wessex Clinical Research Network launch their Technology Support Programme (Round 1)

Wessex Clinical Research Network (CRN) and Wessex Academic Health Science Network (AHSN) have teamed up to support commercial innovators gather crucial evidence on their products.  Their new Technology Support Programme (TSP) will help companies to access the NHS’s research infrastructure to obtain high quality evidence on the economic and health gains their products can bring.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.

OBN Noticeboard

This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc.  Just drop an email to us,, and we will post.